Clinical Trials Directory

Trials / Conditions / Grade 3b Follicular Lymphoma

Grade 3b Follicular Lymphoma

11 registered clinical trials studyying Grade 3b Follicular Lymphoma — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingCD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
NCT06026319
Marcela V. Maus, M.D.,Ph.D.Phase 1
RecruitingStudy Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
NCT05890352
SWOG Cancer Research NetworkPhase 2
RecruitingTesting Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lym
NCT05633615
SWOG Cancer Research NetworkPhase 2
Active Not RecruitingAcalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas
NCT05583149
Patrick C. Johnson, MDPhase 2
RecruitingTafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Lar
NCT05455697
University of WashingtonPhase 1 / Phase 2
SuspendedTesting CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diag
NCT04799275
National Cancer Institute (NCI)Phase 2 / Phase 3
TerminatedCopanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymph
NCT04156828
University of WashingtonPhase 1
Active Not RecruitingPembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.
NCT03150329
City of Hope Medical CenterPhase 1
UnknownAn Italian Experience on Grade 3b Follicular Lymphoma
NCT02927717
A.O.U. Città della Salute e della Scienza—
CompletedPembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell
NCT02541565
University of WashingtonPhase 1
Approved For MarketingExpanded Access Program for Epcoritamab
NCT05733650
Genmab—